No headlines found.
Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence
Globe Newswire (Tue, 24-Mar 9:00 AM ET)
Business Wire (Tue, 3-Mar 10:00 AM ET)
Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results
Globe Newswire (Thu, 26-Feb 6:00 AM ET)
Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26
Globe Newswire (Thu, 22-Jan 9:00 AM ET)
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Privia Health Group trades on the NASDAQ stock market under the symbol PRVA.
As of March 30, 2026, PRVA stock price was flat at $20.02 with 709,806 million shares trading.
PRVA has a beta of 0.65, meaning it tends to be less sensitive to market movements. PRVA has a correlation of 0.13 to the broad based SPY ETF.
PRVA has a market cap of $2.46 billion. This is considered a Mid Cap stock.
Last quarter Privia Health Group reported $541 million in Revenue and $.25 earnings per share. This beat revenue expectation by $22 million and exceeded earnings estimates by $.12.
In the last 3 years, PRVA traded as high as $30.15 and as low as $15.92.
The top ETF exchange traded funds that PRVA belongs to (by Net Assets): IJR, VTI, VB, IWM, VBK.
PRVA has underperformed the market in the last year with a price return of -12.7% while the SPY ETF gained +12.7%. PRVA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -17.0% and -7.7%, respectively, while the SPY returned -8.2% and -4.3%, respectively.
PRVA support price is $19.51 and resistance is $20.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PRVA shares will trade within this expected range on the day.